Trump Administration Used Compounding Pharmacies To Pressure Pharma Bros To Bring Down Pricing Of GLP1s In The US
The Trump administration’s aggressive push to reduce prescription med costs has had a measurable impact on the pricing of GLP-1 treatments in the United States, and compounding pharmacies played a central role in creating the competitive pressure that made it happen. In a recent episode of the Huberman Lab podcast, Dr. Abud Bakri, an internal … Read more